Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting Conference

Scholarly Activity

related documents

Effectiveness of Sofosbuvir/Velpatasvir for 12 Weeks in HCV Genotype 3 Patients with Compensated Cirrhosis in Clinical Practice Cohorts from Around the World Conferences
PRIOR THERAPY WITH SOFOSBUVIR/VELPATASVIR ASSOCIATED WITH REDUCED RESPONSE TO SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR: RESULTS FROM A CANADIAN PROSPECTIVE REGISTRY Conferences